Literature DB >> 26997320

Rebuttal from Max C. Petersen and Michael J. Jurczak.

Max C Petersen1, Michael J Jurczak2,3.   

Abstract

Year:  2016        PMID： 26997320      PMCID： PMC4800027          DOI： 10.1113/JP272137

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  8 in total

1.  CrossTalk opposing view: Intramyocellular ceramide accumulation does not modulate insulin resistance.

Authors:  Max C Petersen; Michael J Jurczak
Journal:  J Physiol       Date:  2016-03-20       Impact factor: 5.182

2.  CrossTalk proposal: Intramyocellular ceramide accumulation does modulate insulin resistance.

Authors:  Scott A Summers; Bret H Goodpaster
Journal:  J Physiol       Date:  2016-03-20       Impact factor: 5.182

3.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

Authors:  Sarah M Turpin; Hayley T Nicholls; Diana M Willmes; Arnaud Mourier; Susanne Brodesser; Claudia M Wunderlich; Jan Mauer; Elaine Xu; Philipp Hammerschmidt; Hella S Brönneke; Aleksandra Trifunovic; Giuseppe LoSasso; F Thomas Wunderlich; Jan-Wilhelm Kornfeld; Matthias Blüher; Martin Krönke; Jens C Brüning
Journal:  Cell Metab       Date:  2014-10-07       Impact factor: 27.287

4.  Reducing plasma membrane sphingomyelin increases insulin sensitivity.

Authors:  Zhiqiang Li; Hongqi Zhang; Jing Liu; Chien-Ping Liang; Yan Li; Yue Li; Gladys Teitelman; Thomas Beyer; Hai H Bui; David A Peake; Youyan Zhang; Phillip E Sanders; Ming-Shang Kuo; Tae-Sik Park; Guoqing Cao; Xian-Cheng Jiang
Journal:  Mol Cell Biol       Date:  2011-08-15       Impact factor: 4.272

5.  Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.

Authors:  Jonathan Y Xia; William L Holland; Christine M Kusminski; Kai Sun; Ankit X Sharma; Mackenzie J Pearson; Angelika J Sifuentes; Jeffrey G McDonald; Ruth Gordillo; Philipp E Scherer
Journal:  Cell Metab       Date:  2015-07-16       Impact factor: 27.287

6.  Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome.

Authors:  Guang Yang; Leylla Badeanlou; Jacek Bielawski; Amanda J Roberts; Yusuf A Hannun; Fahumiya Samad
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-12       Impact factor: 4.310

7.  Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.

Authors:  Mark J Dekker; Chris Baker; Mark Naples; Josh Samsoondar; Rianna Zhang; Wei Qiu; Jennifer Sacco; Khosrow Adeli
Journal:  Atherosclerosis       Date:  2013-02-10       Impact factor: 5.162

8.  Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

Authors:  William L Holland; Russell A Miller; Zhao V Wang; Kai Sun; Brian M Barth; Hai H Bui; Kathryn E Davis; Benjamin T Bikman; Nils Halberg; Joseph M Rutkowski; Mark R Wade; Vincent M Tenorio; Ming-Shang Kuo; Joseph T Brozinick; Bei B Zhang; Morris J Birnbaum; Scott A Summers; Philipp E Scherer
Journal:  Nat Med       Date:  2010-12-26       Impact factor: 53.440
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.